Clinical Trial Update: Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial update for lacosamide as add-on therapy in children aged 4 to under 17 with partial onset seizures. The study has completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2018-03-19